Background: Copper is part of antioxidant enzymes and could have a car
diovascular protective effect. A higher cardiovascular risk has been a
ssociated with high as well as low plasma copper levels. Aim: To searc
h for differences in copper intake and plasma levels between patients
with coronary artery or cerebrovascular diseases and normal subjects.
Patients and methods: Zinc and copper intake, plasma levels and serum
lipid levels were measured in 20 patients with cerebrovascular disease
, 20 patients with and acute myocardial infarction and 40 subjects hos
pitalized for elective surgery, that served as controls. Results: Copp
er and zinc intake was below recommended allowances in all subjects. S
erum zinc and copper levels did not differ in the three study groups.
In patients with myocardial infarction a weak correlation was found be
tween serum copper and total cholesterol (r = 0.24; p < 0.05) and LDL
cholesterol (r = 0.31; p < 0.05). Conclusions: No differences in coppe
r levels were found in subjects with atherosclerosis and controls. The
correlation between serum copper and cholesterol deserves further inv
estigation.